✦ LIBER ✦

Who should be really considered as a poor mobilizer in the plerixafor era?

✍ Scribed by Giovanna Andreola; Anna Vanazzi; Davide Radice; Aleksandra Babic; Cristina Rabascio; Mara Negri; Giovanni Martinelli; Daniele Laszlo

Book ID: 119382432
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 175 KB
Volume: 47
Category: Article
ISSN: 1473-0502
DOI: 10.1016/j.transci.2012.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modified natural-cycle in vitro fertiliz

Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders

✍ Isaac-Jacques Kadoch; Simon J. Phillips; François Bissonnette 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Optimizing the Efficacy of Plerixafor as

Optimizing the Efficacy of Plerixafor as a Salvage Option In Poor Mobilizers Following Chemotherapy Plus G-CSF Mobilization

✍ S.T. Kochuparambil; E.R. Mebel; D.L. DeRemer; A.P. Jillella; F.T. Awan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB

What steps should be considered in the p

What steps should be considered in the patient who has had a negative cervical exploration for primary hyperparathyroidism?

✍ Barney Harrison 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Robotic-assisted total mesorectal excisi

Robotic-assisted total mesorectal excision: should it be considered as the technique of choice in the management of rectal cancer?

✍ J. Clark, K. Shetty, M. H. Sodergren, D. R. C. James, S. Purkayastha, T. Athanas 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 383 KB

In all questions, my interest is not in

In all questions, my interest is not in the individual people but in the analytic movement as a whole. It will be hard enough here in Europe in the times to come to keep it going. After all, we are just a handful of people who really have that in mind …

✍ Riccardo Steiner 📂 Article 📅 2011 🏛 Institute of Psychoanalysis 🌐 English ⚖ 602 KB

ANNOUNCEMENTS: 4th Annual Meeting of the

ANNOUNCEMENTS: 4th Annual Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) The Marriott, Irvine, CA, USA 28–31 January 1999, Keystone Symposia Ocular Cell & Molecular Biology (OCMB) Announces Dean Bok, Ph.D. as the winner of the first OCMB Prize, Keystone OCMB Symposium, 1999 Keystone Colorado 5–10 February 1999, Call for Abstracts and Registration Organizers: Steven E. Wilson and Joe Hollyfield Registration and Abstract Forms available from: Keystone Symposia on Molecular and Cellular Biology Drawer 1630 Silverthorn, Colorado 80498 Telephone: 800-253-0685 Fax: 970-262-1525 E-mail: [email protected], XIV International Congress of Eye Research Santa Fe, New Mexico 15–20 October 2000, XV International Congress of Eye Research (2002) Proposals for the International Congress of Eye Research meeting to be held in the year 2002 are now being accepted by the ISER Council. The Jules François Prize of the Belgian Ophthalmological Societies 2000 The aim of the Jules François Prize is to encourage scientific research in ophthalmology. The prize of 10.000 U.S. Dollars will be awarded to a young scientist who has made an important contribution to ophthalmology. Eligibility: All topics in the field of fundamental and/or clinical research in ophthalmology will be considered. The application should be sent jointly with a curriculum vitae, the list of all publications and 3 copies of the candidates' 10 most relevant publications. The candidate should not be older than 40 years by 31 December 1999. Mailing Address: Jules François Foundation Secretary Prof. Dr. M. Hanssens Dienst Oogheelkunde De Pintelaan 185 B-9000 Gent, Belgium

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 235 KB